Skip to main navigation Skip to search Skip to main content

A case of vasculitis in chronic hepatitis C patient treated with pegylated interferon alpha-2a and ribavirin

  • Youn Ho Kim*
  • , Woo Sik Han
  • , Sun Jae Lee
  • , Sung Nam Oh
  • , Do Won Choi
  • , Kwan Soo Byun
  • , Jong Eun Yeon
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

There has been an increase in the number of patients treated with pegylated interferon (PEG-IFN) and ribavirin due to the better antiviral efficacy. The main serious adverse events of PEG-IFN plus ribavirin combination therapy are bone marrow suppression and hemolytic anemia. However, there are few reports of vasculitis occurring during PEG-IFN therapy. We describe a patient who developed vasculitis during the treatment of chronic hepatitis C with PEG-IFN and ribavirin.

Original languageEnglish
Pages (from-to)419-422
Number of pages4
JournalThe Korean journal of hepatology
Volume13
Issue number3
DOIs
Publication statusPublished - 2007
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'A case of vasculitis in chronic hepatitis C patient treated with pegylated interferon alpha-2a and ribavirin'. Together they form a unique fingerprint.

Cite this